Literature DB >> 12686487

Identification of an in vitro insulin receptor substrate-1 phosphorylation site by negative-ion muLC/ES-API-CID-MS hybrid scan technique.

Alexander Beck1, Klaus Moeschel, Martin Deeg, Hans Ulrich Häring, Wolfgang Voelter, Erwin D Schleicher, Rainer Lehmann.   

Abstract

Recently, we reported a fast on-line alkaline micro-liquid chromatography/electrospray-atmospheric pressure ionization/collision-induced dissociation/mass spectrometric approach for sensitive phosphopeptide screening of a tryptic digested protein and subsequent characterization of the identified phosphopeptide. Based on this study, we now applied an improved method for the identification of phosphorylation sites in insulin receptor substrate 1, an important mediator in insulin signal transduction which was phosphorylated in vitro by protein kinase C-zeta. The approach consists of an on-line alkaline negative-ion micro-liquid chromatography/electrospray-atmospheric pressure ionization/collision-induced dissociation/mass spectrometric hybrid scan experiment using a triple-quadrupole mass spectrometer with fractionation and subsequent off-line nanoES-MS (ion trap) analysis of the phosphopeptide-containing fractions. During the liquid chromatography (LC)/ES-MS experiment, the phosphopeptides of the enzymatic digest mixture of the studied insulin receptor substrate 1 fragment were detected under high skimmer potential (API-CID) using phosphorylation-specific m/z 79 marker ions as well as the intact m/z-values of the peptides which were recorded under low skimmer potential. Subsequently, the targeted fractions were analyzed by off-line nanoES-MS/MS and MS(3). Using this approach, serine 318 was clearly identified as a major in vitro protein kinase C-zeta phosphorylation site in the insulin receptor substrate -1 fragment. Together, our results indicate that the applied strategy is useful for unequivocal and fast analysis of phosphorylation sites in low abundant signaling proteins.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12686487     DOI: 10.1016/s1044-0305(03)00122-3

Source DB:  PubMed          Journal:  J Am Soc Mass Spectrom        ISSN: 1044-0305            Impact factor:   3.109


  21 in total

1.  A multidimensional electrospray MS-based approach to phosphopeptide mapping.

Authors:  R S Annan; M J Huddleston; R Verma; R J Deshaies; S A Carr
Journal:  Anal Chem       Date:  2001-02-01       Impact factor: 6.986

Review 2.  Mass spectrometry in proteomics.

Authors:  R Aebersold; D R Goodlett
Journal:  Chem Rev       Date:  2001-02       Impact factor: 60.622

3.  Phospho-proteomics: evaluation of the use of enzymatic de-phosphorylation and differential mass spectrometric peptide mass mapping for site specific phosphorylation assignment in proteins separated by gel electrophoresis.

Authors:  M R Larsen; G L Sørensen; S J Fey; P M Larsen; P Roepstorff
Journal:  Proteomics       Date:  2001-02       Impact factor: 3.984

Review 4.  Analysis of protein phosphorylation using mass spectrometry: deciphering the phosphoproteome.

Authors:  Matthias Mann; Shao En Ong; Mads Grønborg; Hanno Steen; Ole N Jensen; Akhilesh Pandey
Journal:  Trends Biotechnol       Date:  2002-06       Impact factor: 19.536

5.  Selective detection of phosphopeptides in complex mixtures by electrospray liquid chromatography/mass spectrometry.

Authors:  M J Huddleston; R S Annan; M F Bean; S A Carr
Journal:  J Am Soc Mass Spectrom       Date:  1993-09       Impact factor: 3.109

6.  Fragmentation of phosphopeptides in an ion trap mass spectrometer.

Authors:  J P DeGnore; J Qin
Journal:  J Am Soc Mass Spectrom       Date:  1998-11       Impact factor: 3.109

7.  Mapping of phosphorylation sites of gel-isolated proteins by nanoelectrospray tandem mass spectrometry: potentials and limitations.

Authors:  G Neubauer; M Mann
Journal:  Anal Chem       Date:  1999-01-01       Impact factor: 6.986

8.  Parent ion scans of unseparated peptide mixtures.

Authors:  M Wilm; G Neubauer; M Mann
Journal:  Anal Chem       Date:  1996-02-01       Impact factor: 6.986

9.  Chromatographic and mass spectrometric methods for the identification of phosphorylation sites in phosphoproteins.

Authors:  A P Hunter; D E Games
Journal:  Rapid Commun Mass Spectrom       Date:  1994-07       Impact factor: 2.419

10.  Leaving group and gas phase neighboring group effects in the side chain losses from protonated serine and its derivatives.

Authors:  G E Reid; R J Simpson; R A O'Hair
Journal:  J Am Soc Mass Spectrom       Date:  2000-12       Impact factor: 3.109

View more
  5 in total

1.  Protein kinase C-zeta phosphorylates insulin receptor substrate-1, -3, and -4 but not -2: isoform specific determinants of specificity in insulin signaling.

Authors:  Sihoon Lee; Edward G Lynn; Jeong-A Kim; Michael J Quon
Journal:  Endocrinology       Date:  2008-01-17       Impact factor: 4.736

2.  Mass spectral characterization of organophosphate-labeled, tyrosine-containing peptides: characteristic mass fragments and a new binding motif for organophosphates.

Authors:  Lawrence M Schopfer; Hasmik Grigoryan; Bin Li; Florian Nachon; Patrick Masson; Oksana Lockridge
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2009-07-24       Impact factor: 3.205

3.  Phosphorylation of human insulin receptor substrate-1 at Serine 629 plays a positive role in insulin signaling.

Authors:  Moulun Luo; Paul Langlais; Zhengping Yi; Natalie Lefort; Elena A De Filippis; Hyonson Hwang; Christine Y Christ-Roberts; Lawrence J Mandarino
Journal:  Endocrinology       Date:  2007-07-19       Impact factor: 4.736

4.  Modulation of human insulin receptor substrate-1 tyrosine phosphorylation by protein kinase Cdelta.

Authors:  Michael W Greene; Nick Morrice; Robert S Garofalo; Richard A Roth
Journal:  Biochem J       Date:  2004-02-15       Impact factor: 3.857

5.  Effect of insulin levels on the phosphorylation of specific amino acid residues in IRS-1: implications for burn-induced insulin resistance.

Authors:  Xiao-Ming Lu; Victoria F Hamrahi; Ronald G Tompkins; Alan J Fischman
Journal:  Int J Mol Med       Date:  2009-10       Impact factor: 4.101

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.